The histone deacetylase SIRT6 Is a tumor suppressor that controls cancer metabolism

Carlos Sebastián; Bernadette M.M. Zwaans; Dafne M. Silberman; Melissa Gymrek; Alon Goren; Lei Zhong; Oren Ram; Jessica Truelove; Alexander R. Guimaraes; Debra Toiber; Claudia Cosentino; Joel K. Greenson; Alasdair I. MacDonald; Liane McGlynn; Fraser Maxwell; Joanne Edwards; Sofia Giacosa; Ernesto Guccione; Ralph Weissleder; Bradley E. Bernstein; Aviv Regev; Paul G. Shiels; David B. Lombard; Raul Mostoslavsky

doi:10.1016/j.cell.2012.10.047

The histone deacetylase SIRT6 Is a tumor suppressor that controls cancer metabolism

Carlos Sebastián, Bernadette M.M. Zwaans, Dafne M. Silberman, Melissa Gymrek, Alon Goren, Lei Zhong, Oren Ram, Jessica Truelove, Alexander R. Guimaraes, Debra Toiber, Claudia Cosentino, Joel K. Greenson, Alasdair I. MacDonald, Liane McGlynn, Fraser Maxwell, Joanne Edwards, Sofia Giacosa, Ernesto Guccione, Ralph Weissleder, Bradley E. BernsteinAviv Regev, Paul G. Shiels, David B. Lombard^*, Raul Mostoslavsky

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

550 Scopus citations

Abstract

Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism.

Original language	English
Pages (from-to)	1185-1199
Number of pages	15
Journal	Cell
Volume	151
Issue number	6
DOIs	https://doi.org/10.1016/j.cell.2012.10.047
State	Published - 7 Dec 2012
Externally published	Yes

Bibliographical note

Funding Information:
This work was supported by NIH awards GM093072-01 and DK088190-01A1 (R.M.) and GM101171 (D.B.L.), the Sidney Kimmel Cancer Research Foundation (R.M.), the Richard D. and Katherine M. O'Connor Research Fund of the University of Michigan Comprehensive Cancer Center (D.B.L.), the Nathan Shock Center (AG013283; D.B.L.), and the Pardee Foundation (D.B.L.). R.M. is a Howard Goodman Scholar and an MGH Research Scholar. D.B.L. is a New Scholar in Aging of the Ellison Medical Foundation. C.S. is the recipient of a Beatriu de Pinos Postdoctoral Fellowship (Generalitat de Catalunya). M.G. is supported by a National Defense Science and Engineering Graduate Fellowship. D.T. is the recipient of the Brain Power for Israel Foundation. C.C. is supported by a Fellowship from the Fondazione Umberto Veronesi. A.R. is supported by a P50HG006193 from the NHGRI Center of Excellence in Genome Science. D.B.L. would like to thank Dr. Chuxia Deng (NIDDK/NIH) for the floxed SIRT6 mouse strain. We thank Nabeel Bardeesy, Eric Fearon, Alexandros Tzatsos, Polina Paskaleva, Kevin Haigis, Agustina D'Urso, Marco Bezzi, and the Mostoslavsky and Lombard labs for technical advice, reagents, and helpful discussions. We thank the ENCODE Chromatin Project at the Broad Institute for data sharing. R.M. is a member of Sirtris scientific advisory board.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cell.2012.10.047

Cite this

Sebastián, C., Zwaans, B. M. M., Silberman, D. M., Gymrek, M., Goren, A., Zhong, L., Ram, O., Truelove, J., Guimaraes, A. R., Toiber, D., Cosentino, C., Greenson, J. K., MacDonald, A. I., McGlynn, L., Maxwell, F., Edwards, J., Giacosa, S., Guccione, E., Weissleder, R., ... Mostoslavsky, R. (2012). The histone deacetylase SIRT6 Is a tumor suppressor that controls cancer metabolism. Cell, 151(6), 1185-1199. https://doi.org/10.1016/j.cell.2012.10.047

@article{cea3512557cf4b768cd16b7cf169d688,

title = "The histone deacetylase SIRT6 Is a tumor suppressor that controls cancer metabolism",

abstract = "Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism.",

author = "Carlos Sebasti{\'a}n and Zwaans, {Bernadette M.M.} and Silberman, {Dafne M.} and Melissa Gymrek and Alon Goren and Lei Zhong and Oren Ram and Jessica Truelove and Guimaraes, {Alexander R.} and Debra Toiber and Claudia Cosentino and Greenson, {Joel K.} and MacDonald, {Alasdair I.} and Liane McGlynn and Fraser Maxwell and Joanne Edwards and Sofia Giacosa and Ernesto Guccione and Ralph Weissleder and Bernstein, {Bradley E.} and Aviv Regev and Shiels, {Paul G.} and Lombard, {David B.} and Raul Mostoslavsky",

note = "Funding Information: This work was supported by NIH awards GM093072-01 and DK088190-01A1 (R.M.) and GM101171 (D.B.L.), the Sidney Kimmel Cancer Research Foundation (R.M.), the Richard D. and Katherine M. O'Connor Research Fund of the University of Michigan Comprehensive Cancer Center (D.B.L.), the Nathan Shock Center (AG013283; D.B.L.), and the Pardee Foundation (D.B.L.). R.M. is a Howard Goodman Scholar and an MGH Research Scholar. D.B.L. is a New Scholar in Aging of the Ellison Medical Foundation. C.S. is the recipient of a Beatriu de Pinos Postdoctoral Fellowship (Generalitat de Catalunya). M.G. is supported by a National Defense Science and Engineering Graduate Fellowship. D.T. is the recipient of the Brain Power for Israel Foundation. C.C. is supported by a Fellowship from the Fondazione Umberto Veronesi. A.R. is supported by a P50HG006193 from the NHGRI Center of Excellence in Genome Science. D.B.L. would like to thank Dr. Chuxia Deng (NIDDK/NIH) for the floxed SIRT6 mouse strain. We thank Nabeel Bardeesy, Eric Fearon, Alexandros Tzatsos, Polina Paskaleva, Kevin Haigis, Agustina D'Urso, Marco Bezzi, and the Mostoslavsky and Lombard labs for technical advice, reagents, and helpful discussions. We thank the ENCODE Chromatin Project at the Broad Institute for data sharing. R.M. is a member of Sirtris scientific advisory board. ",

year = "2012",

month = dec,

day = "7",

doi = "10.1016/j.cell.2012.10.047",

language = "אנגלית",

volume = "151",

pages = "1185--1199",

journal = "Cell",

issn = "0092-8674",

publisher = "Cell Press",

number = "6",

}

Sebastián, C, Zwaans, BMM, Silberman, DM, Gymrek, M, Goren, A, Zhong, L, Ram, O, Truelove, J, Guimaraes, AR, Toiber, D, Cosentino, C, Greenson, JK, MacDonald, AI, McGlynn, L, Maxwell, F, Edwards, J, Giacosa, S, Guccione, E, Weissleder, R, Bernstein, BE, Regev, A, Shiels, PG, Lombard, DB & Mostoslavsky, R 2012, 'The histone deacetylase SIRT6 Is a tumor suppressor that controls cancer metabolism', Cell, vol. 151, no. 6, pp. 1185-1199. https://doi.org/10.1016/j.cell.2012.10.047

TY - JOUR

T1 - The histone deacetylase SIRT6 Is a tumor suppressor that controls cancer metabolism

AU - Sebastián, Carlos

AU - Zwaans, Bernadette M.M.

AU - Silberman, Dafne M.

AU - Gymrek, Melissa

AU - Goren, Alon

AU - Zhong, Lei

AU - Ram, Oren

AU - Truelove, Jessica

AU - Guimaraes, Alexander R.

AU - Toiber, Debra

AU - Cosentino, Claudia

AU - Greenson, Joel K.

AU - MacDonald, Alasdair I.

AU - McGlynn, Liane

AU - Maxwell, Fraser

AU - Edwards, Joanne

AU - Giacosa, Sofia

AU - Guccione, Ernesto

AU - Weissleder, Ralph

AU - Bernstein, Bradley E.

AU - Regev, Aviv

AU - Shiels, Paul G.

AU - Lombard, David B.

AU - Mostoslavsky, Raul

N1 - Funding Information: This work was supported by NIH awards GM093072-01 and DK088190-01A1 (R.M.) and GM101171 (D.B.L.), the Sidney Kimmel Cancer Research Foundation (R.M.), the Richard D. and Katherine M. O'Connor Research Fund of the University of Michigan Comprehensive Cancer Center (D.B.L.), the Nathan Shock Center (AG013283; D.B.L.), and the Pardee Foundation (D.B.L.). R.M. is a Howard Goodman Scholar and an MGH Research Scholar. D.B.L. is a New Scholar in Aging of the Ellison Medical Foundation. C.S. is the recipient of a Beatriu de Pinos Postdoctoral Fellowship (Generalitat de Catalunya). M.G. is supported by a National Defense Science and Engineering Graduate Fellowship. D.T. is the recipient of the Brain Power for Israel Foundation. C.C. is supported by a Fellowship from the Fondazione Umberto Veronesi. A.R. is supported by a P50HG006193 from the NHGRI Center of Excellence in Genome Science. D.B.L. would like to thank Dr. Chuxia Deng (NIDDK/NIH) for the floxed SIRT6 mouse strain. We thank Nabeel Bardeesy, Eric Fearon, Alexandros Tzatsos, Polina Paskaleva, Kevin Haigis, Agustina D'Urso, Marco Bezzi, and the Mostoslavsky and Lombard labs for technical advice, reagents, and helpful discussions. We thank the ENCODE Chromatin Project at the Broad Institute for data sharing. R.M. is a member of Sirtris scientific advisory board.

PY - 2012/12/7

Y1 - 2012/12/7

N2 - Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism.

AB - Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism.

UR - http://www.scopus.com/inward/record.url?scp=84870874690&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2012.10.047

DO - 10.1016/j.cell.2012.10.047

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 23217706

AN - SCOPUS:84870874690

SN - 0092-8674

VL - 151

SP - 1185

EP - 1199

JO - Cell

JF - Cell

IS - 6

ER -

The histone deacetylase SIRT6 Is a tumor suppressor that controls cancer metabolism

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this